Mycobacterium fortuitum: A Rare Cause of Surgical Site Infection.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
07 Aug 2024
07 Aug 2024
Historique:
medline:
20
8
2024
pubmed:
20
8
2024
entrez:
20
8
2024
Statut:
aheadofprint
Résumé
Mycobacterium fortuitum is a rapidly growing nontuberculous mycobacterium mainly associated with skin, soft tissue and surgical site infections. We report an unusual outbreak of 6 cases of surgical site infection following spinal surgery. Patients received combined intravenous antibiotics, including amikacin, followed by an extended period of oral therapy with favorable clinical outcomes. No instrumentation replacement was performed in any case.
Identifiants
pubmed: 39163342
doi: 10.1097/INF.0000000000004506
pii: 00006454-990000000-00970
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Franco-Paredes C, Marcos LA, Henao-Martínez AF, et al. Cutaneous mycobacterial infections. Clin Microbiol Rev. 2019;32:e00069-18.
Santos A, Cremades R, Rodríguez JC, et al. Activity of various drugs alone or in combination against Mycobacterium fortuitum. J Infect Chemother. 2010;16:64–67.
Singh Bhalla G, Grover N, Singh G, et al. Prevalence of non tuberculous mycobacterial infection in surgical site infections and their antibiotic susceptibility profile. Med J Armed Forces India. 2021;77:343–348.
Nohrenberg M, Wright A, Krause V. Non-tuberculous mycobacterial skin and soft tissue infections in the Northern Territory, Australia, 1989-2021. Int J Infect Dis. 2023;135:125–131.
Chen HY, Chen CY, Huang CT, et al. Skin and soft-tissue infection caused by non-tuberculous mycobacteria in Taiwan, 1997-2008. Epidemiol Infect. 2011;139:121–129.
Laboratorios clínicos. Requisitos para la calidad y la competencia. ISO 15189. 2022. Cited June 18, 2024.
Griffith DE, Aksamit T, Brown-Elliott BA, et al.; ATS Mycobacterial Diseases Subcommittee. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.
Wang J, Huang J, Peng S, et al. A clinical case and a review of Mycobacterium fortuitum infections direct diagnosis approach and treatment in a patient with leg fractures. J Infect Dev Ctries. 2022;16:1650–1654.
Nash KA, Brown-Elliott AB, Wallace RJ. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009;53:1367–1376.
Kothavade RJ, Dhurat RS, Mishra SN, et al. Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria. Eur J Clin Microbiol Infect Dis. 2013;32:161–188.
Erber J, Weidlich S, Tschaikowsky T, et al. Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by mycobacterium fortuitum complex: a case report. BMC Infect Dis. 2024;20:365.
Pizones J, Sanchez Pérez-Grueso FJ, Thompson GH. Postoperativa Infection in Early-Onset Scoliosis. Grow Spine Manag Spinal Disord Young Child. 2022;Chapter 37:569–78.